Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mats Ohlin

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 24, 2002
Selection of antibodies based on antibody kinetic binding propertiesAnn-Christin Malmborg, Nina Nilsson, Mats Ohlin
Virology|December 31, 2002
Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirusJohan Lantto, Jean M Fletcher, Mats Ohlin
The Journal of General Virology|August 31, 1999
Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralizationAndrea Speckner, Diana Glykofrydes, Mats Ohlin, et al.
Molecular Immunology|June 14, 2005
Subtle sequence differences in a tumour-associated peptide epitope translate into major changes in antigenicityJonas Persson, Johan Lantto, Torbjörn Drakenberg, et al.
The FEBS Journal|October 31, 2008
Acoustic microfluidic chip technology to facilitate automation of phage display selectionJonas Persson, Per Augustsson, Tomas Laurell, et al.
Journal of Immunological Methods|April 4, 2006
Transiently binding antibody fragments against Lewis x and sialyl-Lewis xReine Johansson, Mats Ohlin, Bo Jansson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2023
Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineeringArman Izadi, Wael Bahnan, Mats Ohlin, et al.
Frontiers in Allergy|March 13, 2025
Editorial: Allergen-specific antibodies: from basic science to clinical applicationSabine Flicker, Mats Ohlin, Amanda Atanasio, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 24, 2002
Chain shuffling to modify properties of recombinant immunoglobulinsJohan Lantto, Pernilla Jirholt, Yvelise Barrios, et al.
Journal of Immunological Methods|July 15, 2015
A microarray-based reaction rate analysis platform. Is there evidence of validity?Magdalena Godzwon, Mattias Levin, Anna Säll, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Methods in Molecular Biology (Clifton, N.J.)|April 24, 2002
Selection of antibodies based on antibody kinetic binding propertiesAnn-Christin Malmborg, Nina Nilsson, Mats Ohlin
Virology|December 31, 2002
Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirusJohan Lantto, Jean M Fletcher, Mats Ohlin
The Journal of General Virology|August 31, 1999
Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralizationAndrea Speckner, Diana Glykofrydes, Mats Ohlin, et al.
Molecular Immunology|June 14, 2005
Subtle sequence differences in a tumour-associated peptide epitope translate into major changes in antigenicityJonas Persson, Johan Lantto, Torbjörn Drakenberg, et al.
The FEBS Journal|October 31, 2008
Acoustic microfluidic chip technology to facilitate automation of phage display selectionJonas Persson, Per Augustsson, Tomas Laurell, et al.
Journal of Immunological Methods|April 4, 2006
Transiently binding antibody fragments against Lewis x and sialyl-Lewis xReine Johansson, Mats Ohlin, Bo Jansson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2023
Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineeringArman Izadi, Wael Bahnan, Mats Ohlin, et al.
Frontiers in Allergy|March 13, 2025
Editorial: Allergen-specific antibodies: from basic science to clinical applicationSabine Flicker, Mats Ohlin, Amanda Atanasio, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 24, 2002
Chain shuffling to modify properties of recombinant immunoglobulinsJohan Lantto, Pernilla Jirholt, Yvelise Barrios, et al.
Journal of Immunological Methods|July 15, 2015
A microarray-based reaction rate analysis platform. Is there evidence of validity?Magdalena Godzwon, Mattias Levin, Anna Säll, et al.
Pageof 11